← FDA DRUG APPROVALS

FDA ANDA · ANDA084978

MICRAININ

Sponsor: MEDPOINTE PHARM HLC

APPLICATION
ANDA084978
TYPE
ANDA
ORIGINAL APPROVAL
1978-07-31
LATEST ACTION
1992-09-18
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

MICRAININDiscontinued
ASPIRIN 325MG, MEPROBAMATE 200MG · TABLET · ORAL

Approval history

1992-09-18Manufacturing (CMC) · Supplement 11AP
1990-02-20Labeling · Supplement 10AP
1978-07-31OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →